Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anna C. Ferreira
Institutions:
Medical University of South Carolina,
MUSC Hollings Cancer Center
Observed institutions:
Medical University of South Carolina,
MUSC Hollings Cancer Center
ORCID:
0000-0001-5683-3923
Observed ORCID:
0000-0001-5683-3923
OpenAlex ID:
A5129354692
Phase II Trial of Opaganib Addition in Metastatic Castration‐Resistant Prostate Cancer After Disease Progression on Abiraterone or Enzalutamide
2026
·
Jacqueline T. Brown
, Bassel Nazha
, et al.
·
Cancer Medicine
·
4
Day‐30 IL1RL1 , CXCL9 and REG3α are prognostic for survival after mismatched unrelated donor transplantation
2026
·
Trent Wang
, Anna C. Ferreira
, et al.
·
British Journal of Haematology
Shifting perceptions of e-cigarette risk: A secondary analysis from a nationwide, randomized controlled clinical trial of e-cigarettes among smokers
2026
·
Emily M. Barros
, Anna C. Ferreira
, et al.
·
Addictive Behaviors
Show more works
View as search
Works count:
3
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type